PTC Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTCT and other ETFs, options, and stocks.

About PTCT

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.

CEO

Matthew B. Klein

CEOMatthew B. Klein

Employees

995

Employees995

Headquarters

Warren, New Jersey

HeadquartersWarren, New Jersey

Founded

1998

Founded1998

Employees

995

Employees995

PTCT Key Statistics

Market cap

4.27B

Market cap4.27B

Price-Earnings ratio

-9.30

Price-Earnings ratio-9.30

Dividend yield

—

Dividend yield—

Average volume

765.50K

Average volume765.50K

High today

$55.40

High today$55.40

Low today

$44.31

Low today$44.31

Open price

$45.45

Open price$45.45

Volume

1.88M

Volume1.88M

52 Week high

$55.41

52 Week high$55.41

52 Week low

$24.00

52 Week low$24.00

PTCT News

TipRanks 2d

PTC Therapeutics’ Earnings Call: Strong 2024 Amid Challenges

PTC Therapeutics ((PTCT)) has held its Q4 earnings call. Read on for the main highlights of the call. PTC Therapeutics’ recent earnings call painted a picture...

TipRanks 3d

Promising Growth and Financial Stability Make PTC Therapeutics a Strong Buy

PTC Therapeutics (PTCT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Tiago Fauth from Wells Fargo mai...

TipRanks 3d

PTC Therapeutics price target lowered to $72 from $74 at JPMorgan

JPMorgan analyst Eric Joseph lowered the firm’s price target on PTC Therapeutics (PTCT) to $72 from $74 and keeps an Overweight rating on the shares following t...

Analyst ratings

60%

of 15 ratings

Buy

60%

Hold

20%

Sell

20%